Table 1

Subject demographics by treatment allocation

Panel A

Panel B

Panel C


Category

AVI-014 4 μg/kg

AVI-014 4 μg/kg

Filgrastim 4 μg/kg

AVI-014 8 μg/kg

Filgrastim 8 μg/kg


n

8

8

8

8

8


Race n (%)

White

4 (50.0)

2 (25.0)

3 (37.5)

3 (37.5)

1 (12.5)


Black

4 (50.0)

6 (75.0)

5 (62.5)

5 (62.5)

7 (87.5)


Gender n (%)

Male

7 (87.5)

5 (62.5)

4 (50.0)

5 (62.5)

8 (100.0)


Female

1 (12.5)

3 (37.5)

4 (50.0)

3 (37.5)

0 (0.0)


Age (years)

Mean (SD)

33.6 (7.8)

35.4 (6.6)

30.3 (5.1)

33.8 (5.7)

39.6 (7.3)


Weight (kg)

Mean (SD)

78.3 (10.4)

81.2 (12.1)

79.4 (7.9)

76.3 (6.1)

90.6 (11.9)


Height (cm)

Mean (SD)

177 (11)

175 (8)

170 (10)

173 (5)

181 (4)


Varki et al. BMC Clinical Pharmacology 2009 9:2   doi:10.1186/1472-6904-9-2

Open Data